You can learn a lot about the state of your health by the color of your urine. Medical professionals explain what cloudy ...

While it might not be the most talked-about topic, understanding the colour, smell, and frequency of baby pee can give you ...

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in ...

A new guideline on complicated urinary tract infections (UTIs) could redefine treatment in Australia and globally.

A healthy and strong urinary system is a key element in determining the overall health of an individual. This FemiPro review ...

Here's how Sen. Cory Booker did it—and the max for how long most of us can hold off going, according to science.

Global Antimicrobial Resistance Market is valued approximately at USD 4.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.6% over the forecast period 2024-2032.

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...

Pre-specified interim analysis of Phase 3 PIVOT-PO clinical trial of tebipenem HBr in complicated urinary tract infection (cUTI) is expected to be completed in Q2 2025Company expects to complete analy ...

Good news for the millions of women who struggle with urinary tract infections (UTIs). The Food and Drug Administration (FDA) ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...

TUESDAY, March 25, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract infections (uUTIs) in adult women ...